Protagenic Therapeutics I...

NASDAQ: PTIX · Real-Time Price · USD
2.92
-0.15 (-4.89%)
At close: Aug 15, 2025, 3:59 PM
2.88
-1.41%
After-hours: Aug 15, 2025, 07:55 PM EDT

Protagenic Therapeutics Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
1.84M 1.29M 215.19K 541.17K
Short-Term Investments
n/a 2.77M 7.76M 9.83M
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
n/a n/a n/a n/a
Receivables
n/a n/a n/a n/a
Inventory
n/a n/a n/a n/a
Other Current Assets
n/a n/a n/a n/a
Total Current Assets
1.88M 4.2M 8.04M 11.06M
Property-Plant & Equipment
73.05K 123.33K 1.77K n/a
Goodwill & Intangibles
n/a n/a n/a n/a
Total Long-Term Assets
73.05K 123.33K 1.77K n/a
Total Assets
1.96M 4.32M 8.04M 11.06M
Account Payables
102.96K 113.8K 155.49K 278.96K
Deferred Revenue
n/a n/a n/a n/a
Short-Term Debt
n/a n/a 344.23K n/a
Other Current Liabilities
n/a n/a n/a n/a
Total Current Liabilities
942.76K 655.25K 1.12M 799.53K
Long-Term Debt
n/a n/a n/a 318.43K
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
n/a n/a n/a 318.43K
Total Liabilities
942.76K 655.25K 1.12M 1.12M
Total Debt
n/a n/a 344.23K 318.43K
Common Stock
725.00 444.00 434.00 1.72K
Retained Earnings
-36.3M -30.78M -25.78M -22.22M
Comprehensive Income
-129.85K -113.55K -676.91K -248.35K
Shareholders Equity
1.01M 3.67M 6.92M 9.94M
Total Investments
n/a 2.77M 7.76M 9.83M